spacer
home > ict > winter 2020 > the impact of gdpr for health organisations
PUBLICATIONS
International Clinical Trials

The Impact of GDPR for Health Organisations




Privacy concerns have been growing exponentially due to the large amount of information and personal data being stored digitally today. As healthcare, pharmaceutical, and biotechnology companies move towards greater digitisation and store more and more sensitive or regulated data, the risk of cyber security incidents and information leaks increases.

The information can be anywhere, in file servers in the company, user’s computers, mobile devices, internal databases, cloud applications, etc. The productive environment of this industry is becoming connected and automated. This connectivity makes them more susceptible to attacks, and increases the need to secure more points within the lifecycle of information related to patient data.

Patient Data: Especially Valuable and Sensitive

This sector is one where the level of sensitivity of the data is higher. Not all personal data are similar, and although we can change our email address, we cannot change our medical history if it has been stolen or mishandled.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Luis Ángel del Valle is CEO at SealPath and a Telecommunications Engineer from the University of the Basque Country, Spain, with more than 20 years of experience in the area of cybersecurity and communications software. He founded SealPath, a leading company in the protection and control of confidential information, to provide companies with data-centric information protection solutions that allow them to keep their sensitive data under control wherever they are, in an environment where data are increasingly mobile and the security perimeter of companies has become blurred.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Amcor partners with Moda to offer innovative packaging solutions

Amcor is pleased to announce its partnership with Moda vacuum packaging systems in North America and Latin America. By combining Amcor’s shrink bag and rollstock film for meat and cheese with Moda’s system, producers can gain operational efficiencies and drive total cost savings.
More info >>

White Papers

Financial implications of off-site visits in clinical research, perception versus reality

Illingworth Research

The concept of patient centricity is still relatively new within clinical trials. For too long, the most important person in the trial has been overlooked… the patient. Here, we explore the benefits of conducting a more patient-centric trial for the patient, site and sponsor through mobile, or ‘off-site’ visits. These advantages are much greater than purely financial, although the financial implications of running a more patient-focused clinical trial may previously have deterred some from this approach. Home nursing in clinical trials continues to be thought of as a high value “premium” service, which many sponsors decline in an attempt to remain within budget for the trial. However, is the actual cost of off-site nursing more expensive than the traditional site model?
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement